glp 1 analogue in india Glp-1 Analogues Market Size, Share & Growth Drivers By 2034 GLP-1 Analogues in the Neurobiology

Insulin secretion is enhanced only when blood glucose is elevated (glucose-dependent mechanism), substantially reducing hypoglycaemia risk compared to sulphonylureas

You can read more about saxagliptin on the NHS website Pregnancy, breastfeeding and fertility while taking saxagliptin Sitagliptin (as own brand, Januvia ) No information is available on the clinical use of sitagliptin during breastfeeding

GLP-1 causes the body to produce more insulin, which is key to reducing glucose levels in the blood

Retrieved 22 February 2025

Ochsner Health pioneers new treatments, deploys emerging technologies and performs groundbreaking research, including 4,000 patients enrolled in 685 clinical studies in 2022

------ Dr